Lip Nam Loh

Lip Nam Loh

Auto-generated profile, based on publicly available information

Lip Nam Loh

Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
JHJessica Humann
Jessica Humann
BMBeth Mann
Beth Mann
GGGeli Gao
Geli Gao
PMPhilip Moresco
Philip Moresco
JRJoseph Ramahi
Joseph Ramahi
ETElaine Tuomanen
Elaine Tuomanen

1 June 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
JHJessica Humann
Jessica Humann
BMBeth Mann
Beth Mann
GGGeli Gao
Geli Gao
PMPhilip Moresco
Philip Moresco
JRJoseph Ramahi
Joseph Ramahi
ETElaine Tuomanen
Elaine Tuomanen

10 October 2019 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
CKCarol Kao
Carol Kao
JGJessica Goymer
Jessica Goymer
LLLip Nam Loh
Lip Nam Loh
AMAakash Mahant
Aakash Mahant
CAClare Burn Aschner
Clare Burn Aschner
BHBetsy C. Herold
Betsy C. Herold
Background: Neonatal herpes simplex virus (HSV) disease results in unacceptable morbidity and mortality. The primary humoral immune response to natural infection is neutralizing antibodies (Abs). However, Abs that activate Fc gama receptors (FcγRs) and mediate antibody-dependent cell-mediated cytotoxicity (ADCC) may play a dominant role in protection. In adult mice, a single-cycle HSV candidate vaccine deleted in glycoprotein-D (ΔgD-2) that induces ADCC provided complete protection against HSV disease and prevented the establishment of latency. Passive transfer studies showed that Abs were sufficient for protection. The current study tested the hypothesis that maternal immunization with ΔgD-2 would protect neonates.Methods: C57BL/6 female mice were vaccinated 3 weeks apart with ΔgD-2, and pups were challenged at different times postnatally with lethal doses of HSV-1 or HSV-2. Concentration and functionality of Abs and immune cells were assessed.Results: Maternal ΔgD-2 immunization provided significant protection and reduced viral dissemination after lethal challenge with HSV-1 or HSV-2. Protection correlated with Abs acquired transplacentally or from breastmilk that mediated ADCC. Protection was reduced when pups were challenged on Day 1 of life, and this was associated with decreased ability of newborn cells to mediate Ab-dependent cell killing.Conclusions: Antibodies mediating ADCC provide significant protection against neonatal HSV.

20 September 2017 in Traffic
Verified
Journal Article
Open access
PDF file
LLLip Nam Loh
Lip Nam Loh
EMElizabeth M. C. McCarthy
Elizabeth M. C. McCarthy
PNPriyanka Narang
Priyanka Narang
Naveed Ahmed KhanNaveed Ahmed Khan
Naveed Ahmed Khan
TWTheresa H. Ward
Theresa H. Ward
Eukaryotic cells utilize multiple endocytic pathways for specific uptake of ligands or molecules, and these pathways are commonly hijacked by pathogens to enable host cell invasion. Escherichia coli K1, a pathogenic bacterium that causes neonatal meningitis, invades the endothelium of the blood‐brain barrier, but the entry route remains unclear. Here, we demonstrate that the bacteria trigger an actin‐mediated uptake route, stimulating fluid phase uptake, membrane ruffling and macropinocytosis. The route of uptake requires intact lipid rafts as shown by cholesterol depletion. Using a variety of perturbants we demonstrate that small Rho GTPases and their downstream effectors have a significant effect on bacterial invasion. Furthermore, clathrin‐mediated endocytosis appears to play an indirect role in E. coli K1 uptake. The data suggest that the bacteria effect a complex interplay between the Rho GTPases to increase their chances of uptake by macropinocytosis into human brain microvascular endothelial cells.

1 June 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CPCarl Pierce
Carl Pierce
LLLip Nam Loh
Lip Nam Loh
HSHolly R. Steach
Holly R. Steach
NCNatalia Cheshenko
Natalia Cheshenko
PPPaula Preston-Hurlburt
Paula Preston-Hurlburt
BHBetsy C. Herold
Betsy C. Herold
Herpes simplex virus type 2 (HSV-2) coinfection is associated with increased HIV-1 viral loads and expanded tissue reservoirs, but the mechanisms are not well defined. HSV-2 recurrences result in an influx of activated CD4+ T cells to sites of viral replication and an increase in activated CD4+ T cells in peripheral blood. We hypothesized that HSV-2 induces changes in these cells that facilitate HIV-1 reactivation and replication and tested this hypothesis in human CD4+ T cells and 2D10 cells, a model of HIV-1 latency. HSV-2 promoted latency reversal in HSV-2–infected and bystander 2D10 cells. Bulk and single-cell RNA-Seq studies of activated primary human CD4+ T cells identified decreased expression of HIV-1 restriction factors and increased expression of transcripts including MALAT1 that could drive HIV replication in both the HSV-2–infected and bystander cells. Transfection of 2D10 cells with VP16, an HSV-2 protein that regulates transcription, significantly upregulated MALAT1 expression, decreased trimethylation of lysine 27 on histone H3 protein, and triggered HIV latency reversal. Knockout of MALAT1 from 2D10 cells abrogated the response to VP16 and reduced the response to HSV-2 infection. These results demonstrate that HSV-2 contributes to HIV-1 reactivation through diverse mechanisms, including upregulation of MALAT1 to release epigenetic silencing.

8 March 2017 in mBio
Verified
Journal Article
Open access
PDF file
LLLip Nam Loh
Lip Nam Loh
GGGeli Gao
Geli Gao
ETElaine Tuomanen
Elaine Tuomanen
The Gram-positive bacterial cell wall (CW) peptidoglycan-teichoic acid complex is released into the host environment during bacterial metabolism or death. It is a highly inflammatory Toll-like receptor 2 (TLR2) ligand, and previousin vivostudies have demonstrated its ability to recapitulate pathological features of pneumonia and meningitis. We report that an actin-dependent pathway is involved in the internalization of the CW by epithelial and endothelial cells, in addition to the previously described platelet-activating factor receptor (PAFr)-dependent uptake pathway. Unlike the PAFr-dependent pathway, which is mediated by clathrin and dynamin and does not lead to signaling, the alternative pathway is sensitive to 5-(N-ethyl-N-isopropyl) amiloride (EIPA) and engenders Rac1, Cdc42, and phosphatidylinositol 3-kinase (PI3K) signaling. Upon internalization by this macropinocytosis-like pathway, CW is trafficked to lysosomes. Intracellular CW trafficking is more complex than previously recognized and suggests multiple points of interaction with and without innate immune signaling.IMPORTANCEStreptococcus pneumoniaeis a major human pathogen infecting the respiratory tract and brain. It is an established model organism for understanding how infection injures the host. During infection or bacterial growth, bacteria shed their cell wall (CW) into the host environment and trigger inflammation. A previous study has shown that CW enters and crosses cell barriers by interacting with a receptor on the surfaces of host cells, termed platelet-activating factor receptor (PAFr). In the present study, by using cells that are depleted of PAFr, we identified a second pathway with features of macropinocytosis, which is a receptor-independent fluid uptake mechanism by cells. Each pathway contributes approximately the same amount of cell wall trafficking, but the PAFr pathway is silent, while the new pathway appears to contribute to the host inflammatory response to CW insult.